Advertisement
New Zealand markets open in 5 hours 5 minutes
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5946
    +0.0010 (+0.16%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • OIL

    82.58
    -0.23 (-0.28%)
     
  • GOLD

    2,342.50
    +4.10 (+0.18%)
     

Analyzing Amarin’s Stock Price Movements in November

Analyzing Amarin’s Stock Price Movements in November

On November 12, Amarin (AMRN) stock closed at $19.82, which is 5.84% lower than its previous closing price. On November 10, Amarin issued a press release announcing favorable primary results from the cardiovascular outcomes trial—REDUCE-IT. Despite the favorable outcomes from REDUCE-IT, the stock has been impacted negatively due to queries raised by researchers and cardiologists about the use of mineral oil as a placebo in the cardiovascular outcomes trial.